Rogers Campbell has filed a Form 144 to sell 5,654 shares of Heartflow, Inc., valued at approximately $311,026.54. This filing is significant as it shows ongoing trading activity by insiders within the surgical and medical instruments industry.
Heartflow, Inc., which operates in the surgical and medical instruments and apparatus sector, is based in San Francisco, California. The company was formerly known as Cardiovascular Simulation, Inc. and has a Central Index Key (CIK) of 0001464521. The recent filing was made on October 22, 2026, and is part of a series of filings that include several transactions by Campbell and related parties.
According to the filing, Campbell's sale of shares comes after acquiring them through stock option exercises back in March 2018. The filing states, "Today's trade and sales in the last 90 days occurred in the Sarah Rogers Ttee Campbell Rogers 2019 Irrevocable Trust, of whom Sarah D. Rogers is a trustee and the spouse of Campbell D. Rogers, an officer in the company." This indicates that the sales are part of a broader strategy involving family trusts.
This move may affect market perceptions of Heartflow, especially as insider transactions can signal confidence or concerns about the company's future. The filing shows that Campbell has been active in the market, with multiple sales occurring in the past few months, including sales of 9,219 shares on August 17, 2026, and 13,179 shares on September 18, 2026, which generated gross proceeds of $380,099.37 and $660,926.85, respectively.
As of now, the filing does not specify what actions may follow this sale. However, it reflects a trend of insider activity that could influence investor sentiment moving forward.